Skip to main content

Get the latest public health information from CDC

Clinical Info HIV.gov logo
In affiliation with HIV.gov

Main navigation

  • Home
  • Guidelines
  • Drug Database
  • Glossary
  • Mobile Applications
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
Search Results for:

Guidelines search

  • (-) Adult and Adolescent ARV (20)
  • Adult and Adolescent Opportunistic Infection (33)
  • Caring for Persons with HIV in Disaster Areas (4)
  • COVID-19 and Persons with HIV (Interim Guidance) (1)
  • Pediatric ARV (17)
  • Pediatric Opportunistic Infection (31)
  • Perinatal (16)
Search Results 1 – 20 of 20
HHS Adults and Adolescents Antiretroviral Guidelines Panel Recommendation for the Long-Acting Injectable Antiretroviral Regimen of Cabotegravir and Rilpivirine
Limitations to Treatment Safety and Efficacy
Considerations for Antiretroviral Use in Patients with Coinfections
Appendix A: Key to Acronyms
Appendix B: Drug Characteristics Tables
Laboratory Testing
Management of the Treatment-Experienced Patient
Drug-Drug Interactions
Introduction
Special Patient Populations
Conclusion
What Not to Use
Financial Disclosure
What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
Treatment Goals
Panel Roster
Initiation of Antiretroviral Therapy
What's New in the Guidelines?
Baseline Evaluation
Antiretroviral Therapy to Prevent Sexual Transmission of HIV (Treatment as Prevention)

Connect with us

Facebook
Twitter
Instagram
Subscribe

Mobile Apps

Guidelines
Drug Database
Glossary

Footer menu

  • Home
  • About
  • Mobile Applications
  • News
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.